257 related articles for article (PubMed ID: 36982611)
1. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
Urazov S; Chernov A; Popov O; Klenkova N; Sushentseva N; Polkovnikova I; Apalko S; Kislyuk K; Pavlovich D; Ivanov A; Shcherbak S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982611
[TBL] [Abstract][Full Text] [Related]
2. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Response in COVID-19 Depending on the Severity of the Disease and the Vaccination Status.
Trofin F; Nastase EV; Roșu MF; Bădescu AC; Buzilă ER; Miftode EG; Manciuc DC; Dorneanu OS
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239895
[TBL] [Abstract][Full Text] [Related]
4. Analysis of altered level of blood-based biomarkers in prognosis of COVID-19 patients.
Shrestha MR; Basnet A; Tamang B; Khadka S; Maharjan R; Maharjan R; Chand AB; Thapa S; Rai SK
PLoS One; 2023; 18(8):e0287117. PubMed ID: 37540679
[TBL] [Abstract][Full Text] [Related]
5. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
Front Immunol; 2021; 12():745515. PubMed ID: 34858403
[TBL] [Abstract][Full Text] [Related]
6. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
[TBL] [Abstract][Full Text] [Related]
7. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients.
Elhommosani MR; Sakr MM; Abbas RM; Aboshanab KM
BMC Infect Dis; 2024 Feb; 24(1):231. PubMed ID: 38378528
[TBL] [Abstract][Full Text] [Related]
9. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
10. 'Immune-inflammatory markers & clinical characteristics for outcomes in hospitalized SARS-CoV-2 infected patients of Pakistan: a retrospective analysis'.
Khalid A; Aqeel RF; Nawaz A; Ahmad J; Fatima ST; Shahid S; Rao AA; Aktas G; Ijaz S; Shehryar M
Hematology; 2023 Dec; 28(1):2199629. PubMed ID: 37408482
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19.
Mahmood SBZ; Majid H; Arshad A; Zaib-Un-Nisa ; Niazali N; Kazi K; Aslam A; Ahmed S; Jamil B; Jafri L
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307132
[TBL] [Abstract][Full Text] [Related]
12. Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones.
Haroun RA; Osman WH; Amin RE; Eessa AM; Saad S
Int Immunopharmacol; 2023 Sep; 122():110626. PubMed ID: 37459785
[TBL] [Abstract][Full Text] [Related]
13. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
Sahin O; Aktoz F; Bagci H; Vurgun E
J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
[TBL] [Abstract][Full Text] [Related]
14. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds.
Elnosary ME; Shreadah MA; Ashour ML; Nabil-Adam A
Int Immunopharmacol; 2024 Jan; 126():111072. PubMed ID: 38006751
[TBL] [Abstract][Full Text] [Related]
15. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.
Dwivedi T; Raj A; Das N; Gupta R; Gupta N; Tiwari P; Sahoo B; Sagiraju HKR; Sirohiya P; Ratre B; Elavarasi A; Mohan A; Bhatnagar S
Cureus; 2023 Jun; 15(6):e40273. PubMed ID: 37448393
[TBL] [Abstract][Full Text] [Related]
16. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
[No Abstract] [Full Text] [Related]
17. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
